eicosapentaenoic acid ethyl ester has been researched along with oligonucleotides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassagnol, M; Ezzo, D; Patel, PN | 1 |
| Agarwala, A; Al Rifai, M; Hussain, A; Jia, X; Martin, S; Virani, SS | 1 |
1 review(s) available for eicosapentaenoic acid ethyl ester and oligonucleotides
| Article | Year |
|---|---|
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well.
Topics: Benzhydryl Compounds; Betacoronavirus; Cardiology; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Congresses as Topic; Coronavirus Infections; COVID-19; Eicosapentaenoic Acid; Europe; Glucosides; Humans; Lipid Regulating Agents; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Societies, Medical; Telecommunications | 2020 |
1 other study(ies) available for eicosapentaenoic acid ethyl ester and oligonucleotides
| Article | Year |
|---|---|
New therapeutic alternatives for the management of dyslipidemia.
Topics: Adult; Anticholesteremic Agents; Benzimidazoles; Coronary Disease; Drug Approval; Eicosapentaenoic Acid; Humans; Hypercholesterolemia; Oligonucleotides; United States; United States Food and Drug Administration | 2013 |